Alem A. Belachew

1.8k total citations · 1 hit paper
11 papers, 1.0k citations indexed

About

Alem A. Belachew is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Alem A. Belachew has authored 11 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Hematology and 5 papers in Molecular Biology. Recurrent topics in Alem A. Belachew's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (5 papers) and Kruppel-like factors research (4 papers). Alem A. Belachew is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (5 papers) and Kruppel-like factors research (4 papers). Alem A. Belachew collaborates with scholars based in United States, Italy and France. Alem A. Belachew's co-authors include Animesh Pardanani, Terra L. Lasho, Ayalew Tefferi, Curtis A. Hanson, Christy M. Finke, Rhett P. Ketterling, Emnet A Wassie, Paola Guglielmelli, Alessandro M. Vannucchi and Naseema Gangat and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia.

In The Last Decade

Alem A. Belachew

10 papers receiving 999 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

2014 493 citations Ayalew Tefferi, Paola Guglielmelli et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alem A. Belachew United States	7	950	783	581	326	26	11	1.0k
Laura Villani Italy	11	647 0.7×	508 0.6×	441 0.8×	280 0.9×	14 0.5×	29	753
Carmela Mannarelli Italy	13	996 1.0×	793 1.0×	619 1.1×	385 1.2×	16 0.6×	27	1.1k
Mythri Mudireddy United States	14	870 0.9×	808 1.0×	470 0.8×	254 0.8×	8 0.3×	25	948
Giacomo Coltro Italy	12	501 0.5×	440 0.6×	275 0.5×	181 0.6×	10 0.4×	32	563
Christine Zoi Greece	6	336 0.4×	275 0.4×	226 0.4×	127 0.4×	27 1.0×	10	429
Ronan Chaligné France	8	324 0.3×	296 0.4×	223 0.4×	106 0.3×	29 1.1×	12	439
Elisa Roncoroni Italy	7	587 0.6×	430 0.5×	385 0.7×	252 0.8×	14 0.5×	13	621
Chiara Cavalloni Italy	8	466 0.5×	302 0.4×	314 0.5×	144 0.4×	40 1.5×	15	524
Irène Dobo France	10	377 0.4×	286 0.4×	228 0.4×	165 0.5×	15 0.6×	20	480
Jonas S. Jutzi United States	10	282 0.3×	250 0.3×	238 0.4×	109 0.3×	37 1.4×	21	422

Countries citing papers authored by Alem A. Belachew

Since Specialization

Citations

This map shows the geographic impact of Alem A. Belachew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alem A. Belachew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alem A. Belachew more than expected).

Fields of papers citing papers by Alem A. Belachew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alem A. Belachew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alem A. Belachew. The network helps show where Alem A. Belachew may publish in the future.

Co-authorship network of co-authors of Alem A. Belachew

This figure shows the co-authorship network connecting the top 25 collaborators of Alem A. Belachew. A scholar is included among the top collaborators of Alem A. Belachew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alem A. Belachew. Alem A. Belachew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Belachew, Alem A., Xifeng Wu, Robert Z. Orlowski, et al.. (2021). Genetic determinants of multiple myeloma risk within the Wnt/beta-catenin signaling pathway. Cancer Epidemiology. 73. 101972–101972.

2.

Belachew, Alem A., et al.. (2020). Abstract PR04: Understanding outcome disparities in multiple myeloma: A multiethnic comparison of clinical characteristics in Hispanics. Cancer Epidemiology Biomarkers & Prevention. 29(6_Supplement_2). PR04–PR04. 1 indexed citations

3.

Belachew, Alem A., Yuanqing Ye, Gottumukkala S. Raju, et al.. (2020). Patterns of racial/ethnic disparities in baseline health-related quality of life and relationship with overall survival in patients with colorectal cancer. Quality of Life Research. 29(11). 2977–2986. 14 indexed citations

4.

Belachew, Alem A., Catherine Classen, Krina K. Patel, et al.. (2018). Quality of life and cancer worry in a follow-up cohort of patients with asymptomatic monoclonal gammopathies.. Journal of Clinical Oncology. 36(15_suppl). 8049–8049. 8 indexed citations

5.

Felts, Sara J., Virginia P. Van Keulen, Michael J. Hansen, et al.. (2015). Widespread Non-Canonical Epigenetic Modifications in MMTV-NeuT Breast Cancer. Neoplasia. 17(4). 348–357. 3 indexed citations

6.

Elliott, Michelle A., Animesh Pardanani, Curtis A. Hanson, et al.. (2015). ASXL1 mutations are frequent and prognostically detrimental in CSF3R‐mutated chronic neutrophilic leukemia. American Journal of Hematology. 90(7). 653–656. 62 indexed citations

7.

Tefferi, Ayalew, Emnet A Wassie, Paola Guglielmelli, et al.. (2014). Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients. American Journal of Hematology. 89(8). E121–4. 149 indexed citations

8.

Tefferi, Ayalew, Paola Guglielmelli, Terra L. Lasho, et al.. (2014). CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients. Leukemia. 28(7). 1494–1500. 199 indexed citations

9.

Tefferi, Ayalew, Emnet A Wassie, Terra L. Lasho, et al.. (2014). Calreticulin mutations and long-term survival in essential thrombocythemia. Leukemia. 28(12). 2300–2303. 81 indexed citations

10.

Tefferi, Ayalew, Emnet A Wassie, Kebede H. Begna, et al.. (2014). Revised Cytogenetic Risk Stratification in Primary Myelofibrosis: A Mayo Clinic Study of 903 Patients. Blood. 124(21). 631–631. 2 indexed citations

11.

Tefferi, Ayalew, Paola Guglielmelli, Dirk R. Larson, et al.. (2014). Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. Blood. 124(16). 2507–2513. 493 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact